Libraries enriched for alternatively spliced exons reveal splicing patterns in melanocytes and melanomas

Nature Methods

Volumn 1, Issue 3, 2004, Pages 233-239

  Watahiki, Akira ^a,b   Waki, Kazunori ^a,c   Hayatsu, Norihito ^a,c   Shiraki, Toshiyuki ^a,c   Kondo, Shinji ^c   Nakamura, Mari ^a,c   Sasaki, Daisuke ^c   Arakawa, Takahiro ^c   Kawai, Jun ^a,c   Harbers, Matthias ^d   Nakamura, Yoshihide ^a,b,c,e   Carninci, Piero ^a,c  

^a RIKEN   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c RIKEN YOKOHAMA INSTITUTE   (Japan)

^d Tsukuba Branch   (Japan)

^e YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PEPTIDE LIBRARY; TUMOR MARKER;

ALTERNATIVE RNA SPLICING; ANIMAL; ARTICLE; DNA SEQUENCE; EVALUATION; EXON; GENETICS; MELANOCYTE; MELANOMA; METHODOLOGY; MOLECULAR CLONING; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; TUMOR CELL LINE; VALIDATION STUDY;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CLONING, MOLECULAR; EXONS; MELANOCYTES; MELANOMA; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL;

EID: 21044451858     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth719     Document Type: Article

References (44)

1. Shoemaker, D.D. et al. Experimental annotation of the human genome using microarray technology. Nature 409, 922-927 (2001).
2. Zavolan, M. et al. Impact of alternative initiation, splicing, and termination on the diversity of the mRNA transcripts encoded by the mouse transcriptome. Genome Res. 13, 1290-1300 (2003).
3. Brett, D. et al. EST comparison indicates 38% of human mRNAs contain possible alternative splice forms. FEBS Lett. 474, 83-86 (2000).
4. Croft, L. et al. ISIS, the intron information system, reveals the high frequency of alternative splicing in the human genome. Nat. Genet. 24, 340-341 (2000).
5. Liang, F. et al. Gene index analysis of the human genome estimates approximately 120, 000 genes. Nat Genet. 25, 239-240 (2000).
6. Okazaki, Y. et al. Analysis of the mouse transcriptome based on functional annotation of 60, 770 full-length cDNAs. Nature 420, 563-573 (2002).
7. Krawczak, M., Reiss, J. & Cooper, D.N. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences. Hum. Genet. 90, 41-45 (1992).
8. Caceres, J.F. & Kornblihtt, A.R. Alternative splicing: Multiple control mechanisms and involvement in human disease. Trends Genet. 18, 186-193 (2002).
9. Faustino, N.A. & Cooper, T.A. Pre-mRNA splicing and human disease. Genes Dev. 17, 419-437 (2003).
10. Barrass, J.D. & Beggs, J.D. Splicing goes global. Trends Genet. 19, 295-298 (2003).
11. Castle, J. et al. Optimization of oligonucleotide arrays and RNA amplification protocols for analysis of transcript structure and alternative splicing. Genome Biol. 4, R66 (2003).
12. Johnson, J.M. et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302, 2141-2144 (2003).
13. Bartel, F., Taubert, H. & Harris, L.C. Alternative and aberrant splicing of MDM2 mRNA in human cancer. Cancer Cell 2, 9-15 (2002).
14. Loo, J.C. et al. Germline splicing mutations of CDKN2A predispose to melanoma. Oncogene 22, 6387-6394 (2003).
15. Houghton, A.N. & Polsky, D. Focus on melanoma. Cancer Cell 2, 275-278 (2002).
16. Stekel, D.J., Git, Y. & Falciani, F. The comparison of gene expression from multiple cDNA libraries. Genome Res. 10, 2055-2061 (2000).
17. Huang, X. On global sequence alignment. Comput. Appl. Biosci. 10, 227-235 (1994).
18. Zorn, A.M. Wnt signalling: Antagonistic Dickkopfs. Curr. Biol. 11, R592-R595 (2001).
19. Zhang, Y. et al. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell Biol. 5, 578-581 (2003).
20. Kaul, R. et al. Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice. Int. J. Cancer 103, 606-615 (2003).
21. Sarangarajan, R., Budev, A., Zhao, Y., Gahl, W.A. & Boissy, R.E. Abnormal translocation of tyrosinase and tyrosinase-related protein 1 in cutaneous melanocytes of Hermansky-Pudlak Syndrome and in melanoma cells transfected with anti-sense HPS1 cDNA. J. Invest. Dermatol. 117, 641-646 (2001).
22. Keresztes, G., Mutai, H. & Heller, S. TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins. BMC Genomics 4, 24 (2003).
23. Ramoz, N. et al. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat. Genet. 32, 579-581 (2002).
24. Sini, P., Cannas, A., Koleske, A.J., Di Fiore, P.P. & Scita, G. Abl-dependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation. Nat. Cell Biol. 6, 268-274 (2004).
25. Lin, W.H. et al. Cloning, mapping, and characterization of the human sorbin and SH3 domain containing 1 (SORBS1) gene: A protein associated with c-Abl during insulin signaling in the hepatoma cell line Hep3B. Genomics 74, 12-20 (2001).
26. Liang, Y. et al. NudeL functions in membrane traffic mainly through association with Lisl and cytoplasmic dynein. J. Cell Biol. 164, 557-566 (2004).
27. Haft, C.R., de la Luz Sierra, M., Barr, V.A., Haft, D.H. & Taylor, S.I. Identification of a family of sorting nexin molecules and characterization of their association with receptors. Mol. Cell. Biol. 18, 7278-7287 (1998).
28. Li, B., Cong, F., Tan, C.P., Wang, S.X. & Goff, S.P. Aph2, a protein with a zf-DHHC motif, interacts with c-Abl and has pro-apoptotic activity. J. Biol. Chem. 277, 28870-28876 (2002).
29. Burge, C. & Karlin, S. Prediction of complete gene structures in human genomic DNA. J. Mol. Biol. 268, 78-94 (1997).
30. Ge, K. et al. Mechanism for elimination of a tumor suppressor: Aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc. Natl. Acad. Sci. USA 96, 9689-9694 (1999).
31. Carninci, P. et al Targeting a complex transcriptome: The construction of the mouse full-length cDNA encyclopedia. Genome Res. 13, 1273-1289 (2003).
32. Shiraki, T. et al. Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage. Proc. Natl. Acad. Sci. USA 100, 15776-15781 (2003).
33. Sazani, P. & Kole, R. Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. J. Clin. Invest. 112, 481-486 (2003).
34. Vacek, M., Sazani, P. & Kole, R. Antisense-mediated redirection of mRNA splicing. Cell. Mol. Life Sci. 60, 825-833 (2003).
35. Mercatante, D.R. & Kole, R. Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: Effects on gene expression. Biochim. Biophys. Acta 1587, 126-132 (2002).
36. Le Fur, N., Kelsall, S.R., Silvers, W.K. & Mintz, B. Selective increase in specific alternative splice variants of tyrosinase in murine melanomas: A projected basis for immunotherapy. Proc. Natl. Acad. Sci. USA 94, 5332-5337 (1997).
37. Le Fur, N., Silvers, W.K., Kelsall, S.R. & Mintz, B. Up-regulation of specific tyrosinase mRNAsin mouse melanomas with the c2j gene substituted for the wild-type tyrosinase aLLeLe: Utilization in design of syngeneic immunotherapy models. Proc. Natl. Acad. Sci. USA 94, 7561-7565 (1997).
38. Bracco, L. & Kearsey, J. The relevance of alternative RNA splicing to pharmacogenomics. Trends Biotechnol. 21, 346-353 (2003).
39. Camargo, A.A. et al. The contribution of 700, 000 ORF sequence tags to the definition of the human transcriptome. Proc. Natl. Acad. Sci. USA 98, 12103-12108 (2001).
40. Burset, M., Seledtsov, I.A. & Solovyev, V.V. SpliceDB: Database of canonical and non-canonical mammalian splice sites. Nucleic Acids Res. 29, 255-259 (2001).
41. Wang, H. et al. Gene structure-based splice variant deconvolution using a microarry platform. Bioinformatics 19 Suppl 1, I315-I322 (2003).
42. Carr, K.M., Bittner, M. & Trent, J.M. Gene-expression profiling in human cutaneous melanoma. Oncogene 22, 3076-3080 (2003).
43. Chin, L. The genetics of malignant melanoma: Lessons from mouse and man. Nat. Rev. Cancer 3, 559-570 (2003).
44. Bowtell, D. & Sambrook, J. (eds.). DNA Microarrays: A Molecular Cloning Manual (Cold Spring Harbor Laboratory Press, New York, 2003).